Suhexiang Pill for Acute Ischemic Stroke: A Registry Study
NCT05833932 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-06-11
Summary
The primary purpose of this study is to investigate the effectiveness and safety of the Suhexiang Pill for patients with acute ischemic stroke in real-world settings.
Conditions
Interventions
- DRUG
-
Suhexiang Pill
Suhexiang Pill is an approved traditional Chinese patent medicine.
Sponsors & Collaborators
-
Dongzhimen Hospital, Beijing
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- China
Study Locations
More Related Trials
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT05515393 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2
-
For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
NCT05068349 ·Status: RECRUITING ·Phase: PHASE4
-
Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke
NCT04813445 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642 ·Status: RECRUITING ·Phase: PHASE2
-
Thrombolysis Outcome in Ischemic Stroke
NCT04309357 ·Status: COMPLETED
-
Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke
NCT06202378 ·Status: COMPLETED ·Phase: PHASE2
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
NCT03346538 ·Status: TERMINATED ·Phase: PHASE2
-
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
NCT05032053 ·Status: RECRUITING
-
Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
NCT05836740 ·Status: COMPLETED ·Phase: PHASE3
-
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
NCT02059785 ·Status: SUSPENDED ·Phase: PHASE2
-
Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
NCT05955326 ·Status: RECRUITING ·Phase: PHASE4
-
A Single Ascending Dose of HRS-4029 in Healthy Subjects
NCT06905314 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
1-year Clinical Outcomes in Recombinant Tissue Plasminogen Activator (Rt-PA) Treated Chinese Acute Ischaemic Stroke (AIS) Patients
NCT05395338 ·Status: COMPLETED
-
Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
NCT00821821 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
NCT07279493 ·Status: RECRUITING ·Phase: PHASE2
-
Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic Stroke
NCT05644223 ·Status: UNKNOWN
-
Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke
NCT04142151 ·Status: UNKNOWN ·Phase: NA
-
SY007 in Patients With Acute Ischemic Stroke
NCT04891913 ·Status: SUSPENDED ·Phase: PHASE1
-
The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke
NCT05663307 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
NCT04952064 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Mildronate for Acute Ischemic Stroke
NCT01800357 ·Status: UNKNOWN ·Phase: PHASE2
-
Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke
NCT05035953 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke
NCT05686070 ·Status: COMPLETED ·Phase: PHASE3